K211136: VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML) (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K211136 (VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML), cleared 2021-06-14 for bioMerieux, Inc.) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K211136 |
| Cleared Device Trade / Generic Name | VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML) |
| FDA Applicant on Filing | bioMerieux, Inc. |
| FDA 3-Letter Product Classification | Product Code LON |
| FDA Substantial Equivalence Decision Date | 2021-06-14 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Inspect consolidated manufacturer lineage at bioMerieux, Inc., compare peer devices under FDA Product Code LON, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.